Carmat Sa Stock Fundamentals

CXT Stock  EUR 0.88  0.01  1.15%   
Carmat SA fundamentals help investors to digest information that contributes to Carmat SA's financial success or failures. It also enables traders to predict the movement of Carmat Stock. The fundamental analysis module provides a way to measure Carmat SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Carmat SA stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Carmat SA Company Current Valuation Analysis

Carmat SA's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Carmat SA Current Valuation

    
  213.74 M  
Most of Carmat SA's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Carmat SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Carmat SA has a Current Valuation of 213.74 M. This is 98.51% lower than that of the Healthcare sector and 97.66% lower than that of the Medical Instruments & Supplies industry. The current valuation for all Germany stocks is 98.71% higher than that of the company.

Carmat SA Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Carmat SA's current stock value. Our valuation model uses many indicators to compare Carmat SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Carmat SA competition to find correlations between indicators driving Carmat SA's intrinsic value. More Info.
Carmat SA is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Carmat SA's earnings, one of the primary drivers of an investment's value.

Carmat Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Carmat SA's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Carmat SA could also be used in its relative valuation, which is a method of valuing Carmat SA by comparing valuation metrics of similar companies.
Carmat SA is currently under evaluation in current valuation category among its peers.

Carmat Fundamentals

About Carmat SA Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Carmat SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Carmat SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Carmat SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. The company was founded in 2008 and is based in Vlizy-Villacoublay, France. CARMAT EO operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 119 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Carmat Stock

Carmat SA financial ratios help investors to determine whether Carmat Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Carmat with respect to the benefits of owning Carmat SA security.